|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2002
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life
Children's Hospital of the Ruhr University, Bochum, Germany
CORRESPONDENCE: U. Schauer, Klinik für Kinder- und Jugendmedizin der Ruhr, Universität Bochum, St. Josef-Hospital, Alexandrinenstr. 5, D 44791, Bochum, Germany. Fax: 49 2345092612. E-mail: uwe.schauer@ruhr-uni-bochum.de
Keywords: allergic sensitisation, bronchiolitis, immunoglobulin E, infant, recurrent wheezing, respiratory syncytial virus infection
Received: March 12, 2002
Accepted June 30, 2002
This work was supported by grants from the Bundesministerium für Bildung und Forschung (01GC9801).
Severe respiratory syncytial virus (RSV) infection has been hypothesised to be a risk factor for the development of allergy and asthma, but epidemiological studies in older children have been inconclusive. The current study hypothesises that the effect of RSV bronchiolitis might be most prominent during the first year after bronchiolitis.
Forty-two infants had experienced RSV bronchiolitis severe enough to cause hospitalisation. For each child with RSV infection, two controls were acquired from a birth cohort and matched for date of birth and sex. All the children were followed prospectively and underwent a follow-up examination at a mean age of 1 yr, which included physical examination, and serum immunoglobulin (Ig) E tests for common food and inhaled allergens.
Risk factors for the development of recurrent wheezing and IgE antibodies were analysed for the whole group of 126 children. A positive test for IgE antibodies was noted in 14 of 42 (33%) RSV children and in 2 of 84 (2.3%) children in the control group. RSV bronchiolitis was the most important risk factor for allergic sensitisation. Likewise, 13 children (15.5%) of the RSV group and three (3.6%) children of the control group suffered from recurrent wheezing, and RSV bronchiolitis posed a considerable risk for recurrent wheezing.
Severe respiratory syncytial virus bronchiolitis during the first year of life is an important risk factor for the development of recurrent wheezing and sensitisation to common allergens during the subsequent year.
This article has been cited by other articles:
|
|
 |
|
  R. Kohlmann, S. Schwannecke, B. Tippler, N. Ternette, V. V. Temchura, M. Tenbusch, K. Uberla, and T. Grunwald Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus J. Virol., December 1, 2009; 83(23): 12601 - 12610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bisgaard, A. Flores-Nunez, A. Goh, P. Azimi, A. Halkas, M.-P. Malice, J.-L. Marchal, S. B. Dass, T. F. Reiss, and B. A. Knorr Study of Montelukast for the Treatment of Respiratory Symptoms of Post-Respiratory Syncytial Virus Bronchiolitis in Children Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 854 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Mohapatra and S. Boyapalle Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma Clin. Microbiol. Rev., July 1, 2008; 21(3): 495 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Lee, N. Miyahara, K. Takeda, J. Prpich, A. Oh, A. Balhorn, A. Joetham, E. W. Gelfand, and A. Dakhama IFN-{gamma} Production during Initial Infection Determines the Outcome of Reinfection with Respiratory Syncytial Virus Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 208 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Boukhvalova, G. A. Prince, and J. C. G. Blanco Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity J. Virol., September 1, 2007; 81(17): 9443 - 9450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Subcommittee on Diagnosis and Management of Bronch Diagnosis and Management of Bronchiolitis Pediatrics, October 1, 2006; 118(4): 1774 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, N. Peters, V. Laza-Stanca, N. Nawroly, S. L. Johnston, and J. Schwarze Local CD11c+ MHC Class II- Precursors Generate Lung Dendritic Cells during Respiratory Viral Infection, but Are Depleted in the Process J. Immunol., August 15, 2006; 177(4): 2536 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tayyari, T. C. Sutton, H. E. Manson, and R. G. Hegele CpG-oligodeoxynucleotides inhibit RSV-enhanced allergic sensitisation in guinea pigs Eur. Respir. J., February 1, 2005; 25(2): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sigurs, P. M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, F. Sigurbergsson, and B. Kjellman Severe Respiratory Syncytial Virus Bronchiolitis in Infancy and Asthma and Allergy at Age 13 Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 137 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Z. Wang, Y.-X. Bao, C. L. Rosenberger, Y. Tesfaigzi, J. M. Stark, and K. S. Harrod IL-12p40 and IL-18 Modulate Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection J. Immunol., September 15, 2004; 173(6): 4040 - 4049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schwarze, D. R. O'Donnell, A. Rohwedder, and P. J. M. Openshaw Latency and Persistence of Respiratory Syncytial Virus Despite T Cell Immunity Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 801 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Z. Wang, C. L. Rosenberger, Y.-X. Bao, J. M. Stark, and K. S. Harrod Clara Cell Secretory Protein Modulates Lung Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection J. Immunol., July 15, 2003; 171(2): 1051 - 1060. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |